ISRAEL —Teva Pharmaceuticals Industries Ltd. has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023. Current CEO, Kåre Schultz, will retire effective December 31, 2022. Kare…
Read MoreTag: Israel
Pfizer & CytoReason extend multi-year partnership for AI-driven drug discovery
ISRAEL -CytoReason has extended its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence technology for Pfizer’s drug development programs. According to the deal, Pfizer will invest US$20m in equity,…
Read MoreGlobal consortium seeks to develop breakthrough RNA-based anti-cancer immunotherapy
ISRAEL – The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a global consortium aiming to apply RNA-based therapeutics to…
Read MoreIbex Medical Analytics launches new cancer diagnostics platform
ISRAEL – Israel-based Ibex Medical Analytics has rolled out its new-generation solution, Galen 3.0, for the detection and diagnosis of multiple tissue types across various digital pathology workflows. Galen uses…
Read MoreUltraSight acquires CE Certification for new cardiac AI Technology
SPAIN- Israeli cardiac imaging company UltraSight, has announced that its AI guiding software for cardiac ultrasound now carries the CE Mark. The digital health pioneer received the CE Mark after…
Read MoreNew Survey indicates that 62% of recipients of the monkeypox vaccine report no side effects
ISRAEL- According to a recent study on the adverse effects of the monkeypox vaccine, the majority of vaccine recipients in Israel reported no apparent symptoms. Since the outbreak started, this…
Read MoreTeva closes on US$4.25bn deal to settle US-wide opioid lawsuit
ISRAEL –Teva Pharmaceutical has reached an agreement in principle to settle thousands of lawsuits accusing it of abetting the opioid crisis in the US for up to US$4.25 billion, including…
Read MoreAidoc picks up US$110 million to expand AI care platform
ISRAEL – Aidoc, a maker of AI-based software that helps radiologists read medical scans and alerts them to strokes or pulmonary embolisms, has pulled in a US$110 million Series D…
Read MoreGE Healthcare to invest in Pulsenmore to enter homecare space
ISRAEL – GE Healthcare has agreed to invest up to US$50 million in Israeli start-up Pulsenmore in order to enter the homecare segment and facilitate precision health. The equity investment…
Read MoreSaudi’s pharmacy chain Al Nahdi mulls US$1.3 billion IPO
SAUDI ARABIA –Saudi Arabia’s largest pharmacy retail chain plans to seek US$1.3 billion in an initial public offering in the coming months, Arabian Business has reported, citing sources privy to…
Read More